Allarity Therapeutics (ALLR) Interest & Investment Income (2021 - 2026)
Allarity Therapeutics' (ALLR) quarterly Interest & Investment Income came in at $163000.0 in Q1 2026, down 26.58% YoY from $222000.0 in Q1 2025, and up 5.16% on a QoQ basis from $155000.0 in Q4 2025.
Allarity Therapeutics (ALLR) Interest & Investment Income (2021 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 6 years of Interest & Investment Income data on file, last reported at $163000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 26.58% year-over-year to $163000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $742000.0 (down 1.72% YoY) and the FY2025 annual result came in at $801000.0, up 50.28% from the prior year.
- Interest & Investment Income grew to $163000.0 in Q1 2026, from $155000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $261000.0 in Q3 2024 to a low of $3000.0 in Q2 2023.
- A 5-year average of $103266.7 and a median of $53000.0 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income sank 72.73% — and 2024, when it jumped 7200.0%.
- Tracing ALLR's Interest & Investment Income over 5 years: stood at $11000.0 in 2022, then slumped by 72.73% to $3000.0 in 2023, then jumped by 7200.0% to $219000.0 in 2024, then slipped by 29.22% to $155000.0 in 2025, then gained by 5.16% to $163000.0 in 2026.
- The last three Interest & Investment Income figures came in at $163000.0 (Q1 2026), $155000.0 (Q4 2025), and $187000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | 217,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 163,000.00 |
| Dec 31, 2025 | 155,000.00 |
| Sep 30, 2025 | 187,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | 222,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 261,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Sep 30, 2021 | 28,000.00 |